Ensign Peak Advisors »

Aeglea Biotherapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.9M 83k 23.28
2024-09-30 $2.4M 83k 29.41
2024-06-30 $1.9M 83k 23.51